Back to Search

Study on Cognitive Changes in Alzheimer's Disease

Epidemiology and Biomarker Study in Alzheimer's Disease

Recruiting Phase 3 Interventional Study
Alzheimer Disease
More trials: Alzheimer's clinical trials· Alzheimer's trials in Texas
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Pivotal Trial This treatment is in the last trial phase before FDA approval. Prior Safety Data This treatment has already been tested in at least one earlier human trial. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
55 – 75
Sex
Any
Trial phase
Phase 3
Study type
Interventional
Purpose
Other
Participants needed
3,400 (estimated)
Sponsor
Eli Lilly and Company · Industry
Who this trial is looking for

This trial is looking for people with normal thinking abilities who want to help researchers understand Alzheimer's disease. Participation will last about 7 years and involves assessments of mental function over time.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have normal thinking abilities.

You may not be able to join if

  • I have seen a doctor about memory concerns.
  • I have a history of cognitive impairment or other serious brain diseases.
  • I am enrolled in or have participated in any Alzheimer's drug study.
  • I currently take or have taken prescription medications for memory issues.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

Study AACU determines rates of cognitive worsening in participants within elevated and not elevated plasma P-tau217 cohorts. Participation in AACU will last approximately 7 years.

Trial Locations

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * The participant must self-report unimpaired cognition. * The participant must have adequate literacy, vision, and hearing for neuropsychological assessments at the time of screening. Exclusion Criteria: * Have seen a doctor about memory concerns. * Have a history or diagnosi…
Contacts

Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or

1-317-615-4559

LillyTrials@Lilly.com

CONTACT

Physicians interested in becoming principal investigators please contact

clinical_inquiry_hub@lilly.com

CONTACT

NCT ID: NCT07142954 Source: ClinicalTrials.gov